Strategic Asset Leasing, Inc. (LEAS) Stock
Anew Medical, Inc., located in Omaha, Nebraska, specializes in the creation of biological therapies. These medicines are designed to combat various health issues, including oncological, cardiac, and neurological conditions.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Strategic Asset Leasing, Inc.
Anew Medical, Inc., located in Omaha, Nebraska, specializes in the creation of biological therapies. These medicines are designed to combat various health issues, including oncological, cardiac, and neurological conditions.
Strategic Asset Leasing, Inc. (LEAS) stock trades at $0.00 with a market capitalization of $211458. The stock is valued at a price-to-earnings (P/E) ratio of -0.50, price-to-book of 0.21, price-to-sales of 0.00.
On profitability, Strategic Asset Leasing, Inc. generates a return on equity (ROE) of -100.00%, return on capital employed of -48.71%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: klothoneuro.com